Precise Bio develops a 4D bio-fabrication platform that utilizes proprietary single-cell resolution bio-printing technology to create scalable, patient-specific tissues and organs from their own cells. This technology addresses the need for personalized regenerative solutions in various medical fields, including cardiology and orthopedics, by providing a reliable method for producing functional biological structures.
Funding
$37.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.


CZFounders
Product
Problem
Current tissue engineering techniques often struggle to create scalable, repeatable, and personalized tissues and organs using a patient's own cells. This limitation hinders the development of effective regenerative solutions for various medical fields.
Solution
Precise Bio offers a 4D bio-fabrication platform that addresses these challenges by combining 3D printing with tissue engineering. The platform utilizes proprietary single-cell resolution bio-printing technology to enable the creation of bio-fabricated tissues and organs from a patient's own cells. This integrated approach allows for the production of scalable and repeatable biological structures, offering personalized regenerative solutions for cardiology, orthopedics, dermatology, and other healthcare fields. The technology aims to put existing tissue engineering science into the hands of clinicians, providing a reliable method for producing functional biological structures.
Target Audience
The primary target audience includes clinicians and medical professionals in cardiology, orthopedics, dermatology, and other healthcare fields seeking personalized regenerative solutions.
Features
- Proprietary single-cell resolution bio-printing technology
- Integrated 3D printing and tissue-engineering platform
- Scalable platform enabling mass bio-fabrication
- In-house validated tissue-engineering processes
- 4D printing platform enabling bio-fabrication of tissues